Lv11
80 积分 2025-09-09 加入
Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy
1小时前
待确认
Treatment of Primary Sclerosing Cholangitis Including Transplantation
2小时前
已完结
Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
7天前
已完结
423 | ctDNA‐DIRECTED INTERVENTION WITH EPCORITAMAB ALONE OR IN COMBINATION WITH LENALIDOMIDE‐RITUXIMAB IS FEASIBLE IN THE EARLY POST‐CAR‐T POPULATION AT HIGH RISK OF RELAPSE
10天前
已完结
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study
10天前
已完结
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
11天前
已完结
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
18天前
已完结
An Updated Understanding of Follicular Lymphoma Transformation
19天前
已完结
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
27天前
已完结
Anti-CD19 CAR T Cells in CNS Diffuse Large-B-Cell Lymphoma
27天前
已关闭
皖公网安备34019202002308
